【发布选项】Publishing Options

资源存储库

已于 2024-01-09 10:56:11 修改

阅读量1.9k

点赞数 8

文章标签：笔记

于 2024-01-09 10:23:31 首次发布

本文链接：https://blog.csdn.net/wq6qeg88/article/details/135473757

版权

These are the available publishing options.
这些是可用的发布选项。
If the journal accepts your article, you can change your mind about these options.
如果期刊接受您的文章，您可以改变对这些选项的看法。
Note: editors and reviewers can only see your selection after acceptance.
注意：编辑和审稿人只有在接受后才能看到您的选择。
在这里插入图片描述

Gold Open Access 金牌开放获取

Upon acceptance, my final published journal article will be immediately available to everyone. I need to pay an APC (Article Publishing Charge).
一旦被接受，我最后发表的期刊文章将立即提供给所有人。我需要支付 APC（文章出版费）。
在这里插入图片描述
Subscription 订阅

Upon acceptance, my final published journal article will be immediately available to all journal subscribers, to patients and caregivers, and other groups.
接受后，我最后发表的期刊文章将立即提供给所有期刊订阅者、患者和护理人员以及其他团体。
I understand that I must wait for 24 months before I can share my accepted manuscript publicly in my institution or funder’s repository. I can immediately share it on non-commercial personal homepages and blogs, within my institution, and privately with collaborators.
我知道我必须等待 24 个月才能在我的机构或资助者的存储库中公开分享我接受的手稿。我可以立即在非商业个人主页和博客上、在我的机构内以及与合作者私下分享它。
在这里插入图片描述
Thank you for your Submission.
感谢您的提交。

A PDF of the submission will be provided to the Corresponding Author for Review.
提交的PDF文件将提供给通讯作者进行审查。

PLEASE NOTE: Your submission has not yet been sent to the editorial office.
请注意：您的投稿尚未发送给编辑部。
Your submission is being created. Editorial Manager is taking the files you submitted and creating a PDF.
正在创建您的提交。编辑经理正在获取您提交的文件并创建 PDF。

Because you have designated a different Corresponding Author during the ‘Authors’ step, then this paper will not be available on your Submissions Waiting for Author’s Approval page. The new Corresponding Author will have access to the PDF and must login to the system to approve the PDF before the submission can be sent to the editorial office.
由于您在“作者”步骤中指定了其他通讯作者，因此该论文将不会出现在您的“等待作者批准”页面上。新的通讯作者将有权访问PDF，并且必须登录系统批准PDF，然后才能将投稿发送给编辑部。

The Corresponding Author must go to the Submissions Waiting for Author’s Approval page, where a link to the PDF will appear after it has been built. They must view the PDF and approve the submission. Once the submission is approved, the PDF will be sent to the editorial office.
通讯作者必须转到“等待作者批准的提交”页面，该页面将在构建 PDF 后出现指向 PDF 的链接。他们必须查看 PDF 并批准提交。一旦提交获得批准，PDF将被发送到编辑部。
在这里插入图片描述
Elsevier is deeply committed to fostering a supportive and inclusive scientific community.

爱思唯尔坚定地致力于培养一个支持性和包容性的科学社区。
Your responses to these 3 questions will help us establish action plans and measure progress towards greater diversity, inclusion and equity. This data may be used to improve diversity across editorial processes but is otherwise analyzed and reported in aggregate. Your responses will not be visible or used when evaluating journal submissions. For more information, see our FAQs.
您对这 3 个问题的回答将有助于我们制定行动计划并衡量在实现更大多样性、包容性和公平性方面的进展。这些数据可用于改善编辑流程的多样性，但除此之外，还会进行汇总分析和报告。在评估期刊投稿时，您的回复将不可见或使用。有关更多信息，请参阅我们的常见问题解答。
What are your ethnic origins or ancestry?
你的种族血统或血统是什么？
Select all geographic areas from which your ancestors first originated.
选择您的祖先最初起源的所有地理区域。
Western Europe (e.g., Greece, Sweden, United Kingdom)
西欧（例如希腊、瑞典、英国）
Eastern Europe (e.g., Hungary, Poland, Russia)
东欧（如匈牙利、波兰、俄罗斯）
North Africa (e.g., Egypt, Morocco, Sudan)
北非（例如埃及、摩洛哥、苏丹）
Sub-Saharan Africa (e.g., Kenya, Nigeria, South Africa)
撒哈拉以南非洲（例如肯尼亚、尼日利亚、南非）
West Asia / Middle East (e.g., Iran, Israel, Saudi Arabia)
西亚/中东（例如伊朗、以色列、沙特阿拉伯）
South and Southeast Asia (e.g., India, Indonesia, Singapore)
南亚和东南亚（例如印度、印度尼西亚、新加坡）
East and Central Asia (e.g., China, Japan, Uzbekistan)
东亚和中亚（如中国、日本、乌兹别克斯坦）
Pacific / Oceania (e.g., Australia, Fiji, Papua New Guinea)
太平洋/大洋洲（例如澳大利亚、斐济、巴布亚新几内亚）
North America (Canada, United States)
北美（加拿大、美国）
Central America and Caribbean (e.g., Jamaica, Mexico, Panama)
中美洲和加勒比地区（如牙买加、墨西哥、巴拿马）
South America (e.g., Brazil, Chile, Colombia)
南美洲（例如巴西、智利、哥伦比亚）
Self describe
自我描述

I prefer not to disclose
我不想透露

在这里插入图片描述
Elsevier is deeply committed to fostering a supportive and inclusive scientific community.

I prefer not to disclose
我不想透露
在这里插入图片描述
It is important that you read and accept the guidelines for Ethics in Publishing before you submit your paper. Please ensure you tick the checkbox “I accept” in the last column of the table before approving the PDF of your submission.
在提交论文之前，请务必阅读并接受出版伦理准则。请确保在批准您提交的 PDF 之前勾选表格最后一列中的“我接受”复选框。
在这里插入图片描述

Publishing ethics 出版伦理

The formal component of the scholarly communication system, that is to say the publication of an article in a peer reviewed learned journal, serves many purposes outside of simple communication. It is a building block in the development of a coherent and respected network of knowledge. It is prima facie evidence for the quality and impact of the research work of its authors and by extension the institutions that support them. It supports, and is itself an example, of the scientific method. For all these reasons and more, it is important to lay down standards of expected ethical behaviour by all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society for society-owned or sponsored journals. This includes all parties treating each other with respect and dignity and without discrimination, harassment, bullying or retaliation.
学术交流系统的正式组成部分，即在同行评审的学术期刊上发表文章，除了简单的交流之外，还有许多目的。它是发展连贯和受人尊敬的知识网络的基石。这是其作者以及支持他们的机构的研究工作的质量和影响的初步证据。它支持科学方法，而且本身就是科学方法的一个例子。由于所有这些原因以及更多原因，重要的是制定参与出版行为的所有各方的预期道德行为标准：作者、期刊编辑、同行评审员、出版商和协会拥有或赞助的期刊。这包括各方相互尊重和尊严，不受歧视、骚扰、欺凌或报复。

These guidelines are designed specifically for primary research journals, but may also be relevant for review and other professional publications as well. Individual journals will often have more elaborate or more distinct ethical procedures, generally reflected in their Guide for Authors, and many journals also accept and are in many cases founding participants with respect to discipline-specific standards or standard-setting bodies, such as the International Council of Medical Journal Editors (ICMJE) and Consolidated Standards of Reporting Trials (CONSORT).
这些指南是专门为主要研究期刊设计的，但也可能与评论和其他专业出版物相关。个别期刊通常会有更详细或更独特的伦理程序，通常反映在其作者指南中，许多期刊也接受并在许多情况下是特定学科标准或标准制定机构的创始参与者，例如国际医学期刊编辑委员会（ICMJE）和报告试验综合标准（CONSORT）。

Quick links: 快速链接：

●
Publishing Ethics Resource Kit (PERK)
出版道德资源工具包（PERK）

●
Ethics on Researcher Academy
研究人员学院的伦理学(opens in new tab/window)

Duties of the Publisher 发布者的职责
Guardianship of the scholarly record
学术记录的监护权
These guidelines have been written with all these requirements in mind but especially recognising that it is an important role of the publisher to support the huge efforts made by journal editors, and the often unsung volunteer work undertaken by peer reviewers, in maintaining the integrity of the scholarly record. Although ethical codes inevitably concentrate on the infractions that sometimes occur, it is a tribute to scholarly practice that the system works so well and that problems are comparatively rare. The publisher has a supporting, investing and nurturing role in the scholarly communication process but is also ultimately responsible for ensuring that best practice is followed in its publications3 , 4.
这些指南在编写时考虑到了所有这些要求，但特别认识到，出版商的重要作用是支持期刊编辑为维护学术记录的完整性所做的巨大努力，以及同行评审员通常默默无闻的志愿工作。尽管道德准则不可避免地集中在有时发生的违规行为上，但该系统运作良好且问题相对较少，这是对学术实践的致敬。出版商在学术交流过程中发挥着支持、投资和培育的作用，但最终也有责任确保其出版物遵循最佳实践 3 , 4 。

Elsevier, as the world’s leading journal publisher, takes its duties of guardianship over the scholarly record extremely seriously. Our journals record “the minutes of science” and we recognise our responsibilities as the keeper of those “minutes” in all our policies5, not least the ethical guidelines that we have adopted here.
爱思唯尔作为世界领先的期刊出版商，非常重视其对学术记录的监护职责。我们的期刊记录了“科学会议记录”，我们认识到我们作为我们所有政策 5 中这些“会议记录”的守护者的责任，尤其是我们在这里采用的道德准则。

Elsevier is adopting these policies and procedures to support editors, reviewers and authors in performing their ethical duties under these guidelines. We work with other publishers and industry associations to set standards for best practices on ethical matters, errors and retractions.
爱思唯尔正在采用这些政策和程序来支持编辑、审稿人和作者履行这些准则下的道德义务。我们与其他出版商和行业协会合作，为道德问题、错误和撤稿的最佳实践制定标准。

Safeguard editorial independence
保障编辑独立性
We are committed to ensuring that the potential for advertising, reprint or other commercial revenue has no impact or influence on editorial decisions6.
我们致力于确保潜在的广告、转载或其他商业收入不会影响或影响编辑决策 6 。

Collaborate to set industry best practice
合作制定行业最佳实践
We promote best practice by offering editors membership of the Committee on Publication Ethics (COPE) and providing editors with Crossref Similarity Check reports for all submissions to our editorial systems.
我们通过为编辑提供出版伦理委员会（COPE）的成员资格，并为编辑提供所有提交给我们编辑系统的 Crossref 相似性检查报告来推广最佳实践。

Provide editors with technical, procedural & legal support
为编辑提供技术、程序和法律支持
We support editors in communications with other journals and/or publishers where this is useful to editors and are prepared to provide specialised legal review and counsel if necessary.
我们支持编辑与其他期刊和/或出版商的沟通，这对编辑有用，并准备在必要时提供专门的法律审查和咨询。

Educate researchers on publishing ethics
对研究人员进行出版伦理教育
We also provide extensive education and advice on publishing ethics standards, particularly for early career researchers7.
我们还提供有关出版道德标准的广泛教育和建议，特别是针对早期职业研究人员 7 。

Competing interests for editors who are employees of Elsevier
作为爱思唯尔员工的编辑的利益争夺
Editors of Elsevier’s journals who are employees are required to report any competing or conflicting interests that could affect, or be perceived to affect, their editorial judgement. Competing interests must be reported as soon as they arise, and in any case through an annual declaration, so that they can be assessed and mitigated or resolved. Editorial competing interests may be disclosed on the journal’s website for ongoing competing interests (such as holding a patent), and/or on published papers for competing interests related to the specific paper.
作为雇员的爱思唯尔期刊编辑必须报告任何可能影响或被认为影响其编辑判断的竞争或冲突利益。一旦出现利益冲突，就必须立即报告，无论如何必须通过年度声明进行报告，以便对其进行评估、减轻或解决。编辑竞争利益可能会在期刊网站上披露，以用于持续的竞争利益（例如持有专利），和/或在已发表的论文上披露与特定论文相关的竞争利益。

Competing interests for editors include both financial and non-financial interests, such as:
编辑的竞争利益包括财务和非财务利益，例如：

●
Current academic affiliations or other editorial roles. Examples include: employment, consultancies, professional affiliations, advisory positions, board memberships, or acting as an expert witness (in each case whether paid or unpaid).
目前的学术隶属关系或其他编辑角色。例子包括：就业、咨询、专业隶属关系、顾问职位、董事会成员或担任专家证人（在每种情况下，无论是有偿还是无偿）。

●
Financial interests, including patents or patent applications, travel grants, ownership, directorship. Minor investments in publicly traded stock (less than 1% of the outstanding shares of the publicly traded company) or investments through mutual funds/pension funds/401Ks are excluded.
经济利益，包括专利或专利申请、旅行补助金、所有权、董事职位。对公开交易股票的次要投资（少于上市公司已发行股票的 1%）或通过共同基金/养老基金/401K 进行的投资不包括在内。

Editors who are Elsevier employees are required to comply with Elsevier’s policy on the publication of research articles in Elsevier journals which discourages them from submitting research papers for publication in Elsevier journals, other than when the research was conducted before they joined Elsevier or in exceptional situations such as where the work was presented at a conference and the full conference proceedings are eventually published in an Elsevier journal. In all cases where a research paper is submitted for publication in an Elsevier journal, the Elsevier employee must disclose the conflict to the editor of the journal upon submission and the journal will ensure that all editorial processes are fully independent of the editor-author. If the article is accepted for publication, the article’s declaration of interest statement should disclose that Elsevier is the current employer of an author and that the peer review was fully independent of said author.

All such editors must also comply with Elsevier’s policy regarding non-involvement of editors in papers which they have written or which have been written by family members or colleagues or which relate to products or services in which the editor has an interest.

In addition, editorial staff are forbidden to use information acquired through their work for personal gain. 
作为爱思唯尔员工的编辑必须遵守爱思唯尔关于在爱思唯尔期刊上发表研究文章的政策，该政策不鼓励他们提交研究论文在爱思唯尔期刊上发表，除非在加入爱思唯尔之前进行研究，或者在特殊情况下，例如在会议上发表工作，而完整的会议论文集最终发表在爱思唯尔期刊上。在提交研究论文在爱思唯尔期刊上发表的所有情况下，爱思唯尔员工必须在提交时向期刊编辑披露冲突，期刊将确保所有编辑过程完全独立于编辑-作者。如果文章被接受发表，文章的利益声明应披露爱思唯尔是作者的当前雇主，并且同行评审完全独立于该作者。

所有此类编辑还必须遵守爱思唯尔的政策，即编辑不得参与他们撰写的论文或由家庭成员或同事撰写的论文，或与编辑感兴趣的产品或服务相关的论文。

此外，禁止编辑人员使用通过工作获得的信息谋取私利。

Duties of Editors 编辑的职责
Publication decisions 出版决定
The editor of a learned journal is solely and independently responsible for deciding which of the articles submitted to the journal should be published, often working in conjunction with the relevant society (for society-owned or sponsored journals)4 , 6. The validation of the work in question and its importance to researchers and readers must always underwrite such decisions. The editor may be guided by the policies of the journal’s editorial board and constrained by such legal requirements as shall then be in force regarding issues such as libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers (or society officers) in making these decisions.
学术期刊的编辑全权独立地负责决定哪些提交给该期刊的文章应该发表，通常与相关学会合作（对于学会拥有或赞助的期刊）。 4 , 6 相关作品的验证及其对研究人员和读者的重要性必须始终支持此类决定。编辑可以以期刊编辑委员会的政策为指导，并受到有关诽谤、侵犯版权和剽窃等问题的法律要求的约束。编辑可以与其他编辑或审稿人（或社团官员）协商做出这些决定。

Peer review 同行审查
The editor shall ensure that the peer review process is fair, unbiased, and timely. Research articles must typically be reviewed by at least two external and independent reviewers, and where necessary the editor should seek additional opinions.
编辑应确保同行评审过程公平、公正和及时。研究文章通常必须由至少两名外部独立审稿人进行审稿，必要时编辑应征求其他意见。

The editor shall select reviewers who have suitable expertise in the relevant field, taking account of the need for appropriate, inclusive and diverse representation. The editor shall follow best practice in avoiding the selection of fraudulent peer reviewers8. The editor shall review all disclosures of potential conflicts of interest and suggestions for self-citation made by reviewers in order to determine whether there is any potential for bias.
编辑应选择在相关领域具有适当专业知识的审稿人，同时考虑到适当、包容和多样化的代表性。编辑应遵循最佳实践，避免选择欺诈性的同行评审 8 员。编辑应审查所有潜在利益冲突的披露和审稿人提出的自我引用建议，以确定是否存在任何潜在的偏见。

Fair play 公平竞争
The editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors. When nominating potential editorial board members, the editor shall take account of the need for appropriate, inclusive and diverse representation.
编辑应评估稿件的知识内容，而不考虑作者的种族、性别、性取向、宗教信仰、民族血统、公民身份或政治哲学。在提名潜在的编委会成员时，编辑应考虑到适当、包容和多样化的代表性。

The editorial policies of the journal should encourage transparency and complete, honest reporting, and the editor should ensure that peer reviewers and authors have a clear understanding of what is expected of them. The editor shall use the journal’s standard electronic submission system for all journal communications.
期刊的编辑政策应鼓励透明度和完整、诚实的报道，编辑应确保同行评审员和作者清楚地了解对他们的期望。编辑应使用期刊的标准电子投稿系统进行所有期刊通讯。

The editor shall establish, along with the publisher, a transparent mechanism for appeal against editorial decisions.
编辑应与出版商一起建立对编辑决定提出上诉的透明机制。

Journal metrics 期刊指标
The editor must not attempt to influence the journal’s ranking by artificially increasing any journal metric. In particular, the editor shall not require that references to that (or any other) journal’s articles be included except for genuine scholarly reasons and authors should not be required to include references to the editor’s own articles or products and services in which the editor has an interest.
编辑不得试图通过人为增加任何期刊指标来影响期刊的排名。特别是，编辑不得要求包括对该（或任何其他）期刊文章的引用，除非是出于真正的学术原因，并且不应要求作者包括对编辑自己的文章或编辑感兴趣的产品和服务的引用。

Confidentiality 保密性
The editor must protect the confidentiality of all material submitted to the journal and all communications with reviewers, unless otherwise agreed with the relevant authors and reviewers. In exceptional circumstances and in consultation with the publisher, the editor may share limited information with editors of other journals, institutions, and other organizations that investigate cases of research misconduct where deemed necessary to investigate suspected ethical breaches9.
除非与相关作者和审稿人另有约定，否则编辑必须保护提交给期刊的所有材料以及与审稿人的所有通信的机密性。在特殊情况下，在与出版商协商后，编辑可以与其他期刊、机构和其他调查研究不端行为案件的组织的编辑共享有限的信息，这些组织认为有必要调查涉嫌违反 9 道德的行为。

Unless the journal is operating an open peer-review system and/or reviewers have agreed to disclose their names, the editor must protect reviewers’ identities.
除非期刊运行开放的同行评审系统和/或审稿人同意披露其姓名，否则编辑必须保护审稿人的身份。

Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
未经作者明确书面同意，不得将提交稿件中披露的未发表材料用于编辑自己的研究。通过同行评审获得的特权信息或想法必须保密，不得用于个人利益。

The use of generative AI and AI-assisted technologies in the journal editorial process
生成式人工智能和人工智能辅助技术在期刊编辑过程中的应用
This policy has been triggered by the rise of generative AI and AI-assisted technologies* and aims to provide greater transparency and guidance to authors, editors and reviewers. Elsevier will monitor ongoing developments in this area closely and will adjust or refine the policy as appropriate. The following guidance is specifically for editors.
该政策是由生成式人工智能和人工智能辅助技术*的兴起引发的，旨在为作者、编辑和审稿人提供更大的透明度和指导。爱思唯尔将密切关注这一领域的持续发展，并将酌情调整或完善该政策。以下指南专门针对编辑人员。

A submitted manuscript must be treated as a confidential document. Editors should not upload a submitted manuscript or any part of it into a generative AI tool as this may violate the authors’ confidentiality and proprietary rights and, where the paper contains personally identifiable information, may breach data privacy rights.
提交的稿件必须被视为机密文件。编辑不应将提交的稿件或其任何部分上传到生成式人工智能工具中，因为这可能会侵犯作者的保密性和专有权利，并且如果论文包含个人身份信息，则可能侵犯数据隐私权。

This confidentiality requirement extends to all communication about the manuscript including any notification or decision letters as they may contain confidential information about the manuscript and/or the authors. For this reason, editors should not upload their letters into an AI tool, even if it is just for the purpose of improving language and readability.
此保密要求适用于有关稿件的所有通信，包括任何通知或决定函，因为它们可能包含有关稿件和/或作者的机密信息。出于这个原因，编辑不应该将他们的信件上传到人工智能工具中，即使它只是为了提高语言和可读性。

Peer review is at the heart of the scientific ecosystem and Elsevier abides by the highest standards of integrity in this process. Managing the editorial evaluation of a scientific manuscript implies responsibilities that can only be attributed to humans. Generative AI or AI-assisted technologies should not be used by editors to assist in the evaluation or decision-making process of a manuscript as the critical thinking and original assessment needed for this work is outside of the scope of this technology and there is a risk that the technology will generate incorrect, incomplete or biased conclusions about the manuscript. The editor is responsible and accountable for the editorial process, the final decision and the communication thereof to the authors.
同行评议是科学生态系统的核心，爱思唯尔在此过程中遵守最高的诚信标准。管理科学手稿的编辑评估意味着只能归咎于人类的责任。编辑不应使用生成式人工智能或人工智能辅助技术来协助稿件的评估或决策过程，因为这项工作所需的批判性思维和原创评估超出了该技术的范围，并且该技术可能会对稿件产生不正确、不完整或有偏见的结论。编辑对编辑过程、最终决定及其传达给作者负责。

Elsevier’s AI author policy states that authors are allowed to use generative AI and AI-assisted technologies in the writing process before submission, but only to improve the language and readability of their paper and with the appropriate disclosure, as per our instructions in Elsevier’s Guide for Authors(opens in new tab/window)
爱思唯尔的人工智能作者政策规定，作者可以在投稿前的写作过程中使用生成式人工智能和人工智能辅助技术，但只能根据我们在爱思唯尔作者指南中的说明，改善论文的语言和可读性，并进行适当的披露. Editors can find such disclosure at the bottom of the paper in a separate section before the list of references. If an editor suspects that an author or a reviewer has violated our AI policies, they should inform the publisher.
.编辑可以在论文底部的参考文献列表前的单独部分找到此类披露。如果编辑怀疑作者或审稿人违反了我们的 AI 政策，他们应该通知出版商。

Please note that Elsevier owns identity protected AI-assisted technologies which conform to the RELX Responsible AI Principles(opens in new tab/window)
请注意，爱思唯尔拥有符合RELX负责任AI原则的身份保护AI辅助技术, such as those used during the screening process to conduct completeness and plagiarism checks and identify suitable reviewers. These in-house or licensed technologies respect author confidentiality. Our programs are subject to rigorous evaluation of bias and are compliant with data privacy and data security requirements.
，例如在筛选过程中用于进行完整性和抄袭检查并确定合适的审稿人。这些内部或许可技术尊重作者的机密性。我们的计划经过严格的偏见评估，并符合数据隐私和数据安全要求。

Elsevier embraces new AI-driven technologies that support reviewers and editors in the editorial process, and we continue to develop and adopt in-house or licensed technologies that respect authors’, reviewers’ and editors’ confidentiality and data privacy rights.
爱思唯尔采用新的人工智能驱动技术，在编辑过程中为审稿人和编辑提供支持，我们将继续开发和采用尊重作者、审稿人和编辑的机密性和数据隐私权的内部或许可技术。

Generative AI is a type of artificial intelligence technology that can produce various types of content including text, imagery, audio and synthetic data. Examples include ChatGPT, NovelAI, Jasper AI, Rytr AI, DALL-E, etc.
生成式人工智能是一种人工智能技术，可以生成各种类型的内容，包括文本、图像、音频和合成数据。示例包括 ChatGPT、NovelAI、Jasper AI、Rytr AI、DALL-E 等。

Declaration of competing interests
利益冲突申报
Any potential editorial conflicts of interest should be declared to the publisher in writing prior to the appointment of the editor, and then updated if and when new conflicts arise. The publisher may publish such declarations in the journal.
任何潜在的编辑利益冲突都应在任命编辑之前以书面形式向出版商申报，然后在出现新的冲突时进行更新。出版商可以在期刊上发表此类声明。

The editor must not be involved in decisions about papers which s/he has written him/herself or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Further, any such submission must be subject to all of the journal’s usual procedures, peer review must be handled independently of the relevant author/editor and their research groups, and there should be a clear statement to this effect on any such paper that is published10.
编辑不得参与有关他/她自己撰写的论文或由家人或同事撰写的论文的决定，或与编辑感兴趣的产品或服务有关的论文的决定。此外，任何此类投稿都必须遵守期刊的所有常规程序，同行评审必须独立于相关作者/编辑及其研究小组进行，并且任何发表的 10 此类论文都应有明确的声明。

The editor shall apply Elsevier’s policy relating to the disclosure of potential conflicts of interest by authors and reviewers, e.g. the ICMJE guidelines1.
编辑应适用爱思唯尔关于作者和审稿人披露潜在利益冲突的政策，例如ICMJE指南 1 。

Vigilance over the published record
对已公布的记录保持警惕
The editor should work to safeguard the integrity of the published record by reviewing and assessing reported or suspected misconduct (research, publication, reviewer and editorial), in conjunction with the publisher (or society).
编辑应与出版商（或学会）一起审查和评估报告或可疑的不当行为（研究、出版、审稿人和社论），努力维护已发表记录的完整性。

Such measures will generally include contacting the author of the manuscript or paper and giving due consideration to the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies. The editor shall further make appropriate use of the publisher’s systems for the detection of misconduct, such as plagiarism.
这些措施通常包括与手稿或论文的作者联系，并适当考虑各自的投诉或主张，但也可能包括与相关机构和研究机构的进一步沟通。编辑应进一步适当利用出版商的系统来检测不当行为，例如剽窃。

An editor presented with convincing evidence of misconduct should coordinate with the publisher (and/or society) to arrange the prompt publication of a correction, retraction, expression of concern, or other correction to the record, as may be relevant10.
如果编辑有令人信服的不当行为证据，应与出版商（和/或学会）协调，安排及时发表更正、撤稿、表达关注或对记录的其他更正，视情况而定 10 。

Duties of Reviewers 审稿人的职责
Contribution to editorial decisions
对编辑决策的贡献
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Peer review is an essential component of formal scholarly communication, and lies at the heart of the scientific method. In addition to the specific ethics-related duties described below, reviewers are asked generally to treat authors and their work as they would like to be treated themselves and to observe good reviewing etiquette.
同行评审有助于编辑做出编辑决定，通过与作者的编辑沟通也可以帮助作者改进论文。同行评议是正式学术交流的重要组成部分，也是科学方法的核心。除了下面描述的与道德相关的具体职责外，审稿人通常被要求像对待自己一样对待作者及其作品，并遵守良好的审稿礼仪。

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and decline to participate in the review process.
任何被选中的审稿人如果认为没有资格审查稿件中报告的研究，或者知道无法及时审查，应通知编辑并拒绝参与审查过程。

Confidentiality 保密性
Any manuscripts received for review must be treated as confidential documents. Reviewers must not share the review or information about the paper with anyone or contact the authors directly without permission from the editor.
任何收到审稿的稿件必须被视为机密文件。未经编辑许可，审稿人不得与任何人分享评论或有关论文的信息，也不得直接与作者联系。

Some editors encourage discussion with colleagues or co-reviewing exercises, but reviewers should first discuss this with the editor in order to ensure that confidentiality is observed and that participants receive suitable credit.
一些编辑鼓励与同事讨论或共同审稿，但审稿人应首先与编辑讨论，以确保遵守机密性并确保参与者获得适当的荣誉。

Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
未经作者明确书面同意，不得将投稿稿件中披露的未发表材料用于审稿人自己的研究。通过同行评审获得的特权信息或想法必须保密，不得用于个人利益。

The use of generative AI and AI-assisted technologies in the journal peer review process
生成式人工智能和人工智能辅助技术在期刊同行评审过程中的应用
This policy has been triggered by the rise of generative AI and AI-assisted technologies* and aims to provide greater transparency and guidance to authors, editors and reviewers. Elsevier will monitor ongoing developments in this area closely and will adjust or refine the policy as appropriate. The following guidance is specifically for reviewers.
该政策是由生成式人工智能和人工智能辅助技术*的兴起引发的，旨在为作者、编辑和审稿人提供更大的透明度和指导。爱思唯尔将密切关注这一领域的持续发展，并将酌情调整或完善该政策。以下指南专门针对审阅者。

When a researcher is invited to review another researcher’s paper, the manuscript must be treated as a confidential document. Reviewers should not upload a submitted manuscript or any part of it into a generative AI tool as this may violate the authors’ confidentiality and proprietary rights and, where the paper contains personally identifiable information, may breach data privacy rights.
当研究人员被邀请审阅另一位研究人员的论文时，手稿必须被视为机密文件。审稿人不应将提交的稿件或其任何部分上传到生成式人工智能工具中，因为这可能会侵犯作者的保密性和专有权利，并且如果论文包含个人身份信息，则可能侵犯数据隐私权。

This confidentiality requirement extends to the peer review report, as it may contain confidential information about the manuscript and/or the authors. For this reason, reviewers should not upload their peer review report into an AI tool, even if it is just for the purpose of improving language and readability.
这种保密要求延伸到同行评审报告，因为它可能包含有关稿件和/或作者的机密信息。出于这个原因，审稿人不应该将他们的同行评议报告上传到人工智能工具中，即使它只是为了提高语言和可读性。

Peer review is at the heart of the scientific ecosystem and Elsevier abides by the highest standards of integrity in this process. Reviewing a scientific manuscript implies responsibilities that can only be attributed to humans. Generative AI or AI-assisted technologies should not be used by reviewers to assist in the scientific review of a paper as the critical thinking and original assessment needed for peer review is outside of the scope of this technology and there is a risk that the technology will generate incorrect, incomplete or biased conclusions about the manuscript. The reviewer is responsible and accountable for the content of the review report.
同行评议是科学生态系统的核心，爱思唯尔在此过程中遵守最高的诚信标准。审查科学手稿意味着只能归因于人类的责任。审稿人不应使用生成式人工智能或人工智能辅助技术来协助对论文进行科学审查，因为同行评审所需的批判性思维和原始评估超出了该技术的范围，并且该技术可能会对稿件产生不正确、不完整或有偏见的结论。审稿人对审稿报告的内容负责。

Elsevier’s AI author policy states that authors are allowed to use generative AI and AI-assisted technologies in the writing process before submission, but only to improve the language and readability of their paper and with the appropriate disclosure, as per our instructions in Elsevier’s Guide for Authors(opens in new tab/window)
爱思唯尔的人工智能作者政策规定，作者可以在投稿前的写作过程中使用生成式人工智能和人工智能辅助技术，但只能根据我们在爱思唯尔作者指南中的说明，改善论文的语言和可读性，并进行适当的披露. Reviewers can find such disclosure at the bottom of the paper in a separate section before the list of references.
.审稿人可以在论文底部的参考文献列表前的单独部分找到此类披露。

*Generative AI is a type of artificial intelligence technology that can produce various types of content including text, imagery, audio and synthetic data. Examples include ChatGPT, NovelAI, Jasper AI, Rytr AI, DALL-E, etc.
*生成式人工智能是一种人工智能技术，可以生成各种类型的内容，包括文本、图像、音频和合成数据。示例包括 ChatGPT、NovelAI、Jasper AI、Rytr AI、DALL-E 等。

Alertness to ethical issues
对道德问题的警觉性
A reviewer should be alert to potential ethical issues in the paper and should bring these to the attention of the editor, including any substantial similarity or overlap between the manuscript under consideration and any other published paper of which the reviewer has personal knowledge. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation.
审稿人应警惕论文中潜在的伦理问题，并应提请编辑注意这些问题，包括所考虑的稿件与审稿人个人了解的任何其他已发表论文之间的任何实质性相似或重叠。任何关于先前报告过观察、推导或论点的陈述都应附有相关的引文。

Standards of objectivity & competing interests
客观性标准和利益竞争
Reviews should be conducted objectively. Reviewers should be aware of any personal bias they may have and take this into account when reviewing a paper. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
审查应客观进行。审稿人应该意识到他们可能存在的任何个人偏见，并在审稿时考虑到这一点。对作者的个人批评是不恰当的。裁判员应清楚地表达自己的观点，并提供支持性论据。

Reviewers should consult the Editor before agreeing to review a paper where they have potential conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
审稿人在同意审稿之前应咨询编辑，如果他们与与论文相关的任何作者、公司或机构存在竞争、协作或其他关系或联系，因此存在潜在的利益冲突。

If a reviewer suggests that an author includes citations to the reviewer’s (or their associates’) work, this must be for genuine scientific reasons and not with the intention of increasing the reviewer’s citation count or enhancing the visibility of their work (or that of their associates).
如果审稿人建议作者引用审稿人（或其同事）的工作，这必须是出于真正的科学原因，而不是为了增加审稿人的引用次数或提高他们（或他们的同事）工作的知名度。

Duties of Authors 作者的职责
Reporting standards 报告标准
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.
原创研究报告的作者应准确描述所从事的工作，并对其重要性进行客观讨论。基础数据应在论文中准确表示。论文应包含足够的细节和参考文献，以允许其他人复制该作品。欺诈性或故意不准确的陈述构成不道德的行为，是不可接受的。

Review and professional publication articles should also be accurate and objective, and editorial ‘opinion’ works should be clearly identified as such.
评论和专业出版物文章也应准确客观，编辑“意见”作品应明确标识。

Data access and retention
数据访问和保留
Authors may be asked to provide the research data supporting their paper for editorial review and/or to comply with the open data requirements of the journal. Authors should be prepared to provide public access to such data, if practicable, and should be prepared to retain such data for a reasonable number of years after publication. Authors may refer to their journal’s Guide for Authors for further details.
作者可能会被要求提供支持其论文的研究数据以供编辑审查和/或遵守期刊的开放数据要求。如果可行，作者应准备好向公众提供对此类数据的访问，并应准备在发表后将此类数据保留合理的年限。作者可以参考其期刊的作者指南了解更多详情。

Originality and acknowledgement of sources
原创性和来源确认
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, that this has been appropriately cited or quoted and permission has been obtained where necessary.
作者应确保他们撰写了完全原创的作品，如果作者使用了他人的作品和/或文字，则应适当地引用或引用这些作品和/或文字，并在必要时获得许可。

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have influenced the reported work and that give the work appropriate context within the larger scholarly record. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source.
必须始终对他人的工作给予适当的认可。作者应引用对所报告工作有影响的出版物，并在更大的学术记录中为工作提供适当的背景。未经来源明确书面许可，不得使用或报告私下获得的信息，例如在与第三方的对话、通信或讨论中。

Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical behaviour and is unacceptable.
剽窃有多种形式，从“冒充”他人的论文作为作者自己的论文，到复制或转述他人论文的大部分内容（不注明出处），再到声称他人进行的研究结果。一切形式的剽窃都是不道德的行为，是不可接受的。

Multiple, redundant or concurrent publication
多个、冗余或并发发布
An author should not in general publish manuscripts describing essentially the same research in more than one journal of primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical behaviour and is unacceptable.
一般而言，作者不应在多于一本主要发表的期刊上发表描述基本相同研究的手稿。同时向多个期刊投稿构成不道德行为，是不可接受的。

In general, an author should not submit for consideration in another journal a paper that has been published previously, except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint.
一般而言，作者不应将以前发表的论文提交其他期刊审议，除非以摘要的形式或作为已发表的讲座或学术论文的一部分，或作为电子预印本的形式。

Publication of some kinds of articles (e.g. clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found from the ICMJE1.
在满足某些条件的情况下，在多个期刊上发表某些类型的文章（例如临床指南、翻译）有时是合理的。相关期刊的作者和编辑必须同意二次出版物，该出版物必须反映与原始文件相同的数据和解释。主要参考文献必须在次要出版物中引用。有关可接受的二次出版形式的更多详细信息，请参见 ICMJE 1 。

Confidentiality 保密性
Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.
在保密服务过程中获得的信息，例如审稿或资助申请，未经这些服务所涉及的作品的作者的明确书面许可，不得使用。

Authorship of the paper 论文作者
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made substantial contributions should be listed as co-authors.
作者身份应限于对所报告研究的构思、设计、执行或解释做出重大贡献的人。所有作出重大贡献的人都应被列为合著者。

Where there are others who have participated in certain substantive aspects of the paper (e.g. language editing or medical writing), they should be recognised in the acknowledgements section.
如果还有其他人参与了论文的某些实质性方面（例如语言编辑或医学写作），则应在致谢部分予以认可。

The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
通讯作者应确保论文中包括所有合适的合著者，没有不合适的合著者，并且所有合著者都已查看并批准了论文的最终版本，并同意其提交发表。

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Only in exceptional circumstances will the Editor consider (at their discretion) the addition, deletion or rearrangement of authors after the manuscript has been submitted and the author must clearly flag any such request to the Editor. All authors must agree with any such addition, removal or rearrangement.
作者在提交稿件之前应仔细考虑作者名单和顺序，并在原始提交时提供最终的作者名单。只有在特殊情况下，编辑才会在稿件提交后考虑（自行决定）添加、删除或重新排列作者，并且作者必须向编辑明确说明任何此类请求。所有作者必须同意任何此类添加、删除或重新排列。

Authors take collective responsibility for the work. Each individual author is accountable for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
作者对作品承担集体责任。每个作者都有责任确保与作品任何部分的准确性或完整性相关的问题得到适当的调查和解决。

Individual journals may have particular definitions of authorship (e.g. medical journals may follow the ICMJE definition of authorship1, and authors should ensure that they comply with the policies of the relevant journal.
个别期刊可能对作者身份有特定的定义（例如，医学期刊可以遵循ICMJE对作者身份 1 的定义，作者应确保他们遵守相关期刊的政策。

The use of generative AI and AI-assisted technologies in scientific writing
生成式人工智能和人工智能辅助技术在科学写作中的应用
This policy has been triggered by the rise of generative AI and AI-assisted technologies which are expected to increasingly be used by content creators. The policy aims to provide greater transparency and guidance to authors, readers, reviewers, editors and contributors. Elsevier will monitor this development and will adjust or refine this policy when appropriate. Please note the policy only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.
这项政策是由生成式人工智能和人工智能辅助技术的兴起引发的，预计内容创作者将越来越多地使用这些技术。该政策旨在为作者、读者、审稿人、编辑和贡献者提供更大的透明度和指导。爱思唯尔将密切关注这一发展，并将在适当的时候调整或完善本政策。请注意，该政策仅涉及写作过程，而不是作为研究过程的一部分，使用人工智能工具来分析和从数据中得出见解。

Where authors use generative AI and AI-assisted technologies in the writing process, these technologies should only be used to improve readability and language of the work. Applying the technology should be done with human oversight and control and authors should carefully review and edit the result, because AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. The authors are ultimately responsible and accountable for the contents of the work.
如果作者在写作过程中使用生成式人工智能和人工智能辅助技术，这些技术只能用于提高作品的可读性和语言性。应用该技术应该在人类的监督和控制下完成，作者应该仔细审查和编辑结果，因为人工智能可以生成听起来权威的输出，这些输出可能是不正确的、不完整的或有偏见的。作者对作品内容负有最终责任。

Authors should disclose in their manuscript the use of AI and AI-assisted technologies and a statement will appear in the published work. Declaring the use of these technologies supports transparency and trust between authors, readers, reviewers, editors and contributors and facilitates compliance with the terms of use of the relevant tool or technology.
作者应在其稿件中披露人工智能和人工智能辅助技术的使用，并在已发表的作品中发表声明。声明使用这些技术支持作者、读者、审稿人、编辑和贡献者之间的透明度和信任，并有助于遵守相关工具或技术的使用条款。

Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans. Each (co-) author is accountable for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved and authorship requires the ability to approve the final version of the work and agree to its submission. Authors are also responsible for ensuring that the work is original, that the stated authors qualify for authorship, and the work does not infringe third party rights, and should familiarize themselves with our Ethics in Publishing policy before they submit.
作者不应将人工智能和人工智能辅助技术列为作者或合著者，也不应将人工智能作为作者引用。作者身份意味着只能归因于人类并由人类执行的责任和任务。每个（共同）作者都有责任确保与作品任何部分的准确性或完整性相关的问题得到适当的调查和解决，并且作者身份要求能够批准作品的最终版本并同意其提交。作者还有责任确保作品是原创的，所述作者有资格获得作者身份，并且作品不侵犯第三方权利，并应在提交之前熟悉我们的出版道德政策。

The use of generative AI and AI-assisted tools in figures, images and artwork
在图形、图像和艺术品中使用生成式人工智能和人工智能辅助工具
We do not permit the use of Generative AI or AI-assisted tools to create or alter images in submitted manuscripts. This may include enhancing, obscuring, moving, removing, or introducing a specific feature within an image or figure. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Image forensics tools or specialized software might be applied to submitted manuscripts to identify suspected image irregularities.
我们不允许使用生成式人工智能或人工智能辅助工具来创建或更改提交稿件中的图像。这可能包括增强、模糊、移动、删除或引入图像或图形中的特定特征。亮度、对比度或色彩平衡的调整是可以接受的，只要它们不会遮挡或消除原稿中存在的任何信息。图像取证工具或专用软件可能会应用于提交的稿件，以识别可疑的图像违规行为。

The only exception is if the use of AI or AI-assisted tools is part of the research design or research methods (such as in AI-assisted imaging approaches to generate or interpret the underlying research data, for example in the field of biomedical imaging). If this is done, such use must be described in a reproducible manner in the methods section. This should include an explanation of how the AI or AI-assisted tools were used in the image creation or alteration process, and the name of the model or tool, version and extension numbers, and manufacturer. Authors should adhere to the AI software’s specific usage policies and ensure correct content attribution. Where applicable, authors could be asked to provide pre-AI-adjusted versions of images and/or the composite raw images used to create the final submitted versions, for editorial assessment.
唯一的例外是，如果使用人工智能或人工智能辅助工具是研究设计或研究方法的一部分（例如在人工智能辅助成像方法中，以生成或解释基础研究数据，例如在生物医学成像领域）。如果这样做，则必须在方法部分中以可重现的方式描述此类使用。这应包括解释如何在图像创建或更改过程中使用 AI 或 AI 辅助工具，以及型号或工具的名称、版本和扩展号以及制造商。作者应遵守 AI 软件的特定使用政策，并确保正确的内容归属。在适用的情况下，可以要求作者提供图像的预 AI 调整版本和/或用于创建最终提交版本的复合原始图像，以供编辑评估。

The use of generative AI or AI-assisted tools in the production of artwork such as for graphical abstracts is not permitted. The use of generative AI in the production of cover art may in some cases be allowed, if the author obtains prior permission from the journal editor and publisher, can demonstrate that all necessary rights have been cleared for the use of the relevant material, and ensures that there is correct content attribution.
不允许在图形摘要等艺术品的制作中使用生成式人工智能或人工智能辅助工具。在某些情况下，如果作者事先获得期刊编辑和出版商的许可，可以证明已清除使用相关材料的所有必要权利，并确保有正确的内容归属，则可以允许在封面艺术的制作中使用生成式人工智能。

FAQs 常见问题

Why has Elsevier decided that AI and AI-assisted tools cannot be credited as an author on published work?

Does this policy cover tools that are used to check grammar and spelling, and reference managers that enable authors to collect and organize references to scholarly articles?

Does this policy refer to AI and AI-assisted tools that are used in the research process, for example to process data?

In which section of the manuscript should authors disclose the use of AI-assisted technologies, and where will this statement appear in the article if it is accepted for publication?

Can authors use AI-assisted tools to create or alter images that they publish in their work?

How does Elsevier handle copyright if the authors credit an AI or AI-assisted tool in their article?
Hazards and human or animal subjects
危害和人类或动物受试者
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
如果作品涉及的化学品、程序或设备在使用过程中存在任何不寻常的危害，作者必须在手稿中明确指出这些。

If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
如果作品涉及使用动物或人类受试者，作者应确保手稿包含一份声明，说明所有程序均按照相关法律和机构指南执行，并且适当的机构委员会已批准。作者应在稿件中包括一份声明，说明对人类受试者进行实验已获得知情同意。必须始终遵守人类主体的隐私权。

For human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans11. All animal experiments should comply with the ARRIVE guidelines12 and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act 1986 and associated guidelines13, or EU Directive 2010/63/EU on the protection of animals used for scientific purposes14, or the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and, as applicable, the Animal Welfare Act15.
对于人类受试者，作者应确保所描述的工作已按照世界医学会道德准则（赫尔辛基宣言）进行，用于涉及人类 11 的实验。所有动物实验均应符合 ARRIVE指南，并应按照英国《1986 年动物（科学程序）法》和相关指南 12 13 、欧盟指令 2010/63/EU 关于保护用于科学目的 14 的动物或美国公共卫生服务政策进行实验动物的人道护理和使用，以及如适用，《动物福利法 15 》。

Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author and copies of the consents or evidence that such consents have been obtained must be provided to Elsevier on request16.
如果作者希望在爱思唯尔出版物中包含病例详细信息或其他个人信息或患者和任何其他个人的图像，则必须获得适当的同意、许可和授权。作者必须保留书面同意书，并且必须根据要求 16 向爱思唯尔提供同意书的副本或已获得此类同意的证据。

Declaration of competing interests
利益冲突申报
WAME define conflict of interest as “a divergence between an individual’s private interests (competing interests) and his or her responsibilities to scientific and publishing activities, such that a reasonable observer might wonder if the individual’s behavior or judgment was motivated by considerations of his or her competing interests”17. All authors should disclose in their manuscript any financial and personal relationships with other people or organisations that could be viewed as inappropriately influencing (bias) their work.
WAME将利益冲突定义为“个人的私人利益（竞争利益）与其对科学和出版活动的责任之间的分歧，以至于理性的观察者可能会怀疑个人的行为或判断是否出于对他或她的竞争利益的考虑”。 17 所有作者都应在其稿件中披露与他人或组织的任何财务和个人关系，这些关系可能被视为不恰当地影响（偏见）他们的工作。

All sources of financial support for the conduct of the research and/or preparation of the article should be disclosed, as should the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
应披露进行研究和/或准备文章的所有财政支持来源，以及申办者（如果有）在研究设计中的作用;数据的收集、分析和解释;在撰写报告时;以及提交文章发表的决定。如果资金来源没有这种参与，则应说明这一点。

Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest possible stage17.
应披露的潜在利益冲突的例子包括雇佣、咨询、股票所有权、酬金、有偿专家证词、专利申请/注册以及赠款或其他资金。潜在的利益冲突应尽早披露 17 。

Notification of fundamental errors
基本错误通知
When an author discovers a significant error or inaccuracy in their own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper if deemed necessary by the editor. If the editor or the publisher learn from a third party that a published work contains an error, it is the obligation of the author to cooperate with the editor, including providing evidence to the editor where requested.
当作者发现自己发表的作品存在重大错误或不准确时，作者有义务及时通知期刊编辑或出版商，并在编辑认为必要时配合编辑撤回或更正论文。如果编辑或出版商从第三方获悉已发表的作品包含错误，作者有义务与编辑合作，包括应要求向编辑提供证据。

Image integrity 图像完整性
It is not acceptable to enhance, obscure, move, remove, or introduce a specific feature within an image. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Manipulating images for improved clarity is accepted, but manipulation for other purposes could be seen as scientific ethical abuse and will be dealt with accordingly18.
在图像中增强、模糊、移动、删除或引入特定特征是不可接受的。亮度、对比度或色彩平衡的调整是可以接受的，只要它们不会遮挡或消除原稿中存在的任何信息。为提高清晰度而操纵图像是可以接受的，但出于其他目的的操纵可能被视为科学道德滥用，并将受到相应的处理 18 。

Authors should comply with any specific policy for graphical images applied by the relevant journal, e.g. providing the original images as supplementary material with the article, or depositing these in a suitable repository
作者应遵守相关期刊对图形图像的任何特定政策，例如将原始图像作为文章的补充材料提供，或将其存放在合适的存储库中

Clinical trial transparency
临床试验透明度
Elsevier supports clinical trial transparency. For relevant journals, authors are expected to conform to industry best standards in in clinical trial registration and presentation, for example the CONSORT guidelines, as further set out in the policies of the relevant journal1, 2.
爱思唯尔支持临床试验的透明度。对于相关期刊，作者应在临床试验注册和发表方面符合行业最佳标准，例如CONSORT指南，如相关期刊政策中进一步规定 1, 2 的那样。

资源存储库

关注

8
点赞
踩
10

收藏

觉得还不错? 一键收藏
打赏
0
评论
【发布选项】Publishing Options

我知道我必须等待 24 个月才能在我的机构或资助者的存储库中公开分享我接受的手稿。我可以立即在非商业个人主页和博客上、在我的机构内以及与合作者私下分享它。一旦被接受，我最后发表的期刊文章将立即提供给所有人。我需要支付 APC（文章出版费）。接受后，我最后发表的期刊文章将立即提供给所有期刊订阅者、患者和护理人员以及其他团体。如果期刊接受您的文章，您可以改变对这些选项的看法。注意：编辑和审稿人只有在接受后才能看到您的选择。Gold Open Access 金牌开放获取。这些是可用的发布选项。
复制链接

扫一扫